204 related articles for article (PubMed ID: 27566179)
1. RalA is overactivated in medulloblastoma.
Ginn KF; Fangman B; Terai K; Wise A; Ziazadeh D; Shah K; Gartrell R; Ricke B; Kimura K; Mathur S; Borrego-Diaz E; Farassati F
J Neurooncol; 2016 Oct; 130(1):99-110. PubMed ID: 27566179
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.
Male H; Patel V; Jacob MA; Borrego-Diaz E; Wang K; Young DA; Wise AL; Huang C; Van Veldhuizen P; O'Brien-Ladner A; Williamson SK; Taylor SA; Tawfik O; Esfandyari T; Farassati F
Lung Cancer; 2012 Aug; 77(2):252-9. PubMed ID: 22498113
[TBL] [Abstract][Full Text] [Related]
3. RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC).
Ezzeldin M; Borrego-Diaz E; Taha M; Esfandyari T; Wise AL; Peng W; Rouyanian A; Asvadi Kermani A; Soleimani M; Patrad E; Lialyte K; Wang K; Williamson S; Abdulkarim B; Olyaee M; Farassati F
Mol Oncol; 2014 Jul; 8(5):1043-53. PubMed ID: 24785097
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells.
Frasson C; Rampazzo E; Accordi B; Beggio G; Pistollato F; Basso G; Persano L
Biomed Res Int; 2015; 2015():973912. PubMed ID: 26557719
[TBL] [Abstract][Full Text] [Related]
5. RalBP1 is necessary for metastasis of human cancer cell lines.
Wu Z; Owens C; Chandra N; Popovic K; Conaway M; Theodorescu D
Neoplasia; 2010 Dec; 12(12):1003-12. PubMed ID: 21170262
[TBL] [Abstract][Full Text] [Related]
6. Ral overactivation in malignant peripheral nerve sheath tumors.
Bodempudi V; Yamoutpoor F; Pan W; Dudek AZ; Esfandyari T; Piedra M; Babovick-Vuksanovic D; Woo RA; Mautner VF; Kluwe L; Clapp DW; De Vries GH; Thomas SL; Kurtz A; Parada LF; Farassati F
Mol Cell Biol; 2009 Jul; 29(14):3964-74. PubMed ID: 19414599
[TBL] [Abstract][Full Text] [Related]
7. Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
Lim KH; Baines AT; Fiordalisi JJ; Shipitsin M; Feig LA; Cox AD; Der CJ; Counter CM
Cancer Cell; 2005 Jun; 7(6):533-45. PubMed ID: 15950903
[TBL] [Abstract][Full Text] [Related]
8. Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate.
Pistollato F; Rampazzo E; Persano L; Abbadi S; Frasson C; Denaro L; D'Avella D; Panchision DM; Della Puppa A; Scienza R; Basso G
Stem Cells; 2010 Nov; 28(11):1918-29. PubMed ID: 20827750
[TBL] [Abstract][Full Text] [Related]
9. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
Tecleab A; Zhang X; Sebti SM
J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
[TBL] [Abstract][Full Text] [Related]
10. Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA.
Lim KH; Brady DC; Kashatus DF; Ancrile BB; Der CJ; Cox AD; Counter CM
Mol Cell Biol; 2010 Jan; 30(2):508-23. PubMed ID: 19901077
[TBL] [Abstract][Full Text] [Related]
11. Effects of RAL signal transduction in KRAS- and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer.
Győrffy B; Stelniec-Klotz I; Sigler C; Kasack K; Redmer T; Qian Y; Schäfer R
Oncotarget; 2015 May; 6(15):13334-46. PubMed ID: 26033452
[TBL] [Abstract][Full Text] [Related]
12. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of HOXA10 and HOXB4 in human medulloblastoma cell lines.
Bonfim-Silva R; Ferreira Melo FU; Thomé CH; Abraham KJ; De Souza FAL; Ramalho FS; Machado HR; De Oliveira RS; Cardoso AA; Covas DT; Fontes AM
Int J Oncol; 2017 Dec; 51(6):1929-1940. PubMed ID: 29039487
[TBL] [Abstract][Full Text] [Related]
14. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
[TBL] [Abstract][Full Text] [Related]
15. Ral signaling pathway in health and cancer.
Moghadam AR; Patrad E; Tafsiri E; Peng W; Fangman B; Pluard TJ; Accurso A; Salacz M; Shah K; Ricke B; Bi D; Kimura K; Graves L; Najad MK; Dolatkhah R; Sanaat Z; Yazdi M; Tavakolinia N; Mazani M; Amani M; Ghavami S; Gartell R; Reilly C; Naima Z; Esfandyari T; Farassati F
Cancer Med; 2017 Dec; 6(12):2998-3013. PubMed ID: 29047224
[TBL] [Abstract][Full Text] [Related]
16. Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling.
Tazat K; Harsat M; Goldshmid-Shagal A; Ehrlich M; Henis YI
Mol Biol Cell; 2013 Jun; 24(11):1812-24. PubMed ID: 23576547
[TBL] [Abstract][Full Text] [Related]
17. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
[TBL] [Abstract][Full Text] [Related]
18. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
Fan S; Meng Q; Laterra JJ; Rosen EM
Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
[TBL] [Abstract][Full Text] [Related]
19. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
[TBL] [Abstract][Full Text] [Related]
20. Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
Annabi B; Rojas-Sutterlin S; Laflamme C; Lachambre MP; Rolland Y; Sartelet H; Béliveau R
Mol Cancer Res; 2008 Jun; 6(6):907-16. PubMed ID: 18567795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
